NCT00084149View on ClinicalTrials.gov

Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
HIV Infections
Interventions
DRUG

Abacavir sulfate, Lamivudine, and Zidovudine

antiretroviral therapy

DRUG

Lopinavir/Ritonavir

antiretroviral therapy

Trial Locations (4)

10003

Beth Israel Med. Ctr., ACTU, New York

55455-0392

University of Minnesota, ACTU, Minneapolis

10016-6481

NY Univ. HIV/AIDS CRS, New York

44109-1998

MetroHealth CRS, Cleveland

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00084149 - Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV | Biotech Hunter | Biotech Hunter